**Core tip:** Several age-related DNA methylation alterations could be observed during colorectal cancer (CRC) formation and progression affecting the mRNA expression of certain CRC- and adenoma-related key control genes such as hypermethylated secreted frizzled related protein 1 (*SFRP1*), spectrin repeat containing nuclear envelope protein 1 and hypomethylated cell migration-inducing protein. For the first time significantly lower *SFRP1* methylation levels were demonstrated in colonic tissue from children (under 18 years) compared to healthy adults. The main CRC-associated signal transduction pathways, such as WNT signaling and PI3K/Akt pathways are also influenced during aging.

INTRODUCTION
============

DNA methylation alterations in connection with aging include epigenetic drift and epigenetic clock phenomena. Epigenetic drift is defined as the global DNA methylation changes caused by random and environmental individual-specific factors, while the epigenetic clock is defined as a group of progressive age-related epigenetic alterations at specific genomic sites which are common across individuals and occassionally across various tissue types\[[@B1],[@B2]\]. The epigenetic clock concept is an approach to biological age prediction of different tissues based on the DNA methylation status of 353 CpG sites measured using the Illumina Beadchip450K methylation array platform\[[@B2]\].

Although age-related (A type) and cancer-related (C type) DNA methylation are often distinguished, the main age-related disease is cancer and the age of patients is one of the risk factor for carcinogenesis\[[@B3]\]. In human development, following a transient increase in average DNA methylation in early childhood (during the first year of life)\[[@B4],[@B5]\], global hypomethylation is characteristic during aging\[[@B6],[@B7]\]. Similarly global hypomethylation is observed in various types of cancers including colorectal cancer (CRC)\[[@B8]\]. With aging, besides global hypomethylation, local hypermethylation can occur on promoters of certain genes, including tumor suppressor gene promoters in various types of cancers, and many tumor suppressor genes were reported among the age-dependently hypermethylated genes\[[@B6]\]. Among others, promoter hypermethylation of *APC*\[[@B7],[@B9]-[@B12]\], *CDKN2A*\[[@B7],[@B9]\], *ESR1*\[[@B7],[@B13],[@B14]\], *GATA5*\[[@B15],[@B16]\], *HPP1*\[[@B7],[@B15],[@B17]\], *SFRP1*\[[@B7],[@B12],[@B15],[@B18]-[@B23]\] and *SFRP2*\[[@B7],[@B18]-[@B21]\] genes was reported for colonic tissues during both aging and colorectal carcinogenesis. Although DNA methylation data from adult colonic tissue samples has been expansively published, data for children/young patients are limited.

In this study, we analyzed DNA methylation and/or gene expression changes of genes covered by the 353 epigenetic clock CpG sites\[[@B2]\] for patients of different ages as well as stages in the progression through to CRC in order to study the possible relationship between age-related and cancer-associated epigenetic alterations. Gene expression analysis was performed using colonic tissue samples from healthy children, healthy adults, and patients with adenomas and CRC. Among the differentially methylated/expressed age-related genes, secreted frizzled related protein 1 (*SFRP1*) promoter methylation was further analyzed in healthy, premalignant and cancerous colonic tissue samples, and to our knowledge this is the first study to also include colonic biopsy specimens from children.

MATERIALS AND METHODS
=====================

In silico DNA methylation analysis
----------------------------------

The DNA methylation status of 353 age-related CpG sites\[[@B2]\] was analyzed *in silico* using methylation array data from the Illumina BeadChip450K. Analysis was performed on 123 CRC, adenoma and normal tissue samples available in the NCBI Gene Expression Database database (GEO accession number: GSE48684\[[@B24]\]). Differences between average methylation values of the compared diagnostic groups (Δβ-values) and *P* values were determined for each CpG site (cg IDs). For statistical evaluation, normal distribution was checked using Kolmogorov-Smirnov test. Hence normal distribution was observed in any cases, Student's *t*-test with Benjamini and Hochberg correction was applied for paired group comparisons. Significance criteries were *P \<* 0.05 in all cases.

In silico gene expression analysis
----------------------------------

The expression of age-related "epigenetic clock" genes was analyzed using whole transcriptome data from Affymetrix HGU133 Plus2.0. Data was obtained from 153 colonic biopsy samples (49 healthy, 49 adenoma, 49 CRC and 6 healthy children) previously hybridized by our research group (GEO serial accession numbers: GSE37364\[[@B25]\], GSE10714\[[@B26]\], GSE4183\[[@B27]\], GSE37267\[[@B28]\]). Gene expression levels were compared using unpaired Student's *t*-test with Benjamini and Hochberg correction (*P* value of \< 0.05 was considered as significant). For gene expression analysis, normal distribution was found using Kolmogorov-Smirnov test, therefore Student's *t*-test (in case of differentiation of two groups with equal variances) or Welch-test (in case of differentiation of two groups with unequal variances) and ANOVA (when more than two groups were compared) were applied. For paired comparisons Benjamini and Hochberg correction was applied. In case of ANOVA, Tukey HSD post-test was used in order to find out which group refers to the differentiation if any. Significance criteries were *P \<* 0.05 in any cases. For the logFC calculation, the differences between the averages of groups were considered (abs logFC ≥ 0.5 criteria).

Methyl capture sequencing - in silico data analysis
---------------------------------------------------

Whole methylome data from 6 normal adjacent tissue (NAT), 15 adenoma and 9 CRC tissue samples were determined in a previous study using methyl capture sequencing\[[@B12]\]. Using this dataset, the whole promoter methylation status of genes showing an inverse relation between gene expression and DNA methylation was evaluated. Differentially methylated genes were determined as described earlier\[[@B12]\]. For statistical evaluation normal distribution was determined and the applied tests were chosen according to the above-mentioned criteria. Differences with *P \<* 0.05 were considered as significant. Methylation alterations between diagnostic groups were characterized by Δβ-values (the differences of the average β-values of sample groups).

Clinical samples
----------------

All patients provided informed consent. Colorectal biopsy samples were obtained during routine endoscopic intervention at the 2^nd^ Department of Internal Medicine and 1^st^ Department of Paediatrics, Semmelweis University, Budapest, Hungary. In total 55 colonic tissue samples (from 19 healthy children (under age of 18 years), 8 healthy adults, 20 patients with adenomas and 8 CRC samples) were tested in SFRP1 methylation-specific high resolution melting (MS-HRM) study (Table [1](#T1){ref-type="table"}). Biopsy samples from all adults and 5 of children were stored in RNALater Stabilization Solution (Ambion, ThermoFisher Scientific) at -80 °C until use. Biopsy samples from the same site were immediately fixed in buffered formalin for histological evaluation. For 14 children, only FFPE blocks were available. Histological diagnoses were established by experienced pathologists. Altogether 27 tissue samples (19 from children and 8 from adults) with normal histology (so called healthy normal colonic tissue samples) were involved in SFRP1 MS-HRM study. Children and adults in the study had been referred to the outpatient clinic with rectal bleeding, constipation or chronic abdominal pain. Ileocolonoscopy was part of their diagnostic procedure (exclude organic disease) and the biopsy specimens showed normal macroscopic appearance and histology\[[@B28]\]. The study was conducted according to the Helsinki declaration and approved by the local ethics committee and government authorities (Regional and Institutional Committee of Science and Research Ethics (TUKEB) Nr.: 69/2008, 202/2009 and 23970/2011 Semmelweis University, Budapest, Hungary).

###### 

Clinical data of samples involved in the high resolution melting study

  **Sample ID**   **Age**   **Gender**   **Localization**          **Histology**                       **TNM**   **Grade**   **Dukes' stage (MAC)**   **Dysplasia**   **Adenoma size**              **Sample type**
  --------------- --------- ------------ ------------------------- ----------------------------------- --------- ----------- ------------------------ --------------- ----------------------------- -----------------
  Ch1             4         M            Colon                     Normal                                                                                                                           FFPE
  Ch2             7         F            Cecum                     Normal                                                                                                                           FFPE
  Ch3             11        M            Colon                     Normal                                                                                                                           FFPE
  Ch4             14        M            Transverse                Normal                                                                                                                           FFPE
  Ch5             5         F            Sigmoid                   Normal                                                                                                                           FFPE
  Ch6             7         F            Descendent                Normal                                                                                                                           FFPE
  Ch7             1         M            Descendent                Normal                                                                                                                           FFPE
  Ch8             1         M            Sigmoid                   Normal                                                                                                                           FFPE
  Ch9             10        M            Cecum                     Normal                                                                                                                           FFPE
  Ch10            3         M            Sigmoid                   Normal                                                                                                                           FFPE
  Ch11            17        F            Cecum                     Normal                                                                                                                           FFPE
  Ch12            17        F            Sigmoid                   Normal                                                                                                                           FFPE
  Ch13            16        F            Sigmoid                   Normal                                                                                                                           FFPE
  Ch14            16        F            Cecum                     Normal                                                                                                                           FFPE
  Ch15            1         M            Left colon                Normal                                                                                                                           FF
  Ch16            3         F            Sigmoid                   Normal                                                                                                                           FF
  Ch17            6         M            Sigmoid                   Normal                                                                                                                           FF
  Ch18            9         M            Sigmoid                   Normal                                                                                                                           FF
  Ch19            17        M            Colon                     Normal                                                                                                                           FF
  N1              44        F            Sigmoid                   Normal                                                                                                                           FF
  N2              31        F            Sigmoid                   Normal                                                                                                                           FF
  N3              59        F            Sigmoid                   Normal                                                                                                                           FF
  N4              54        M            Colon                     Normal                                                                                                                           FF
  N5              68        F            Sigmoid                   Normal                                                                                                                           FF
  N6              71        F            Sigmoid                   Normal                                                                                                                           FF
  N7              69        F            Sigmoid                   Normal                                                                                                                           FF
  N8              57        F            Sigmoid                   Normal                                                                                                                           FF
  AD1             78        M            Asc, sigmoid, rectum      Tubulovillous adenoma                                                              Low-grade       30 mm, 3 mm, 15 mm            FF
  AD2             60        M            Sigmoid                   Tubular adenoma                                                                    Low-grade       6 mm                          FF
  AD3             88        M            Asc, transv, sigmoid      Tubular adenoma                                                                    Low-grade       4 mm, 3 mm, 7-8 mm            FF
  AD4             72        F            Rectum                    Tubular adenoma                                                                    Low-grade       10 mm                         FF
  AD5             45        F            Descendent                Tubular adenoma                                                                    High-grade      5-6 mm                        FF
  AD6             68        F            Rectum                    Tubular adenoma                                                                    Low-grade       5 mm                          FF
  AD7             63        F            Sigmoid                   Tubular adenoma                                                                    Low-grade       8 mm                          FF
  AD8             65        F            Asc, transv, rectum       Tubular adenoma                                                                    Low-grade       2-3 mm, 2-3 mm, 2-3 mm        FF
  AD9             60        F            Sigmoid                   Tubular adenoma                                                                    Low-grade       5 mm, 4 mm                    FF
  AD10            77        F            Rectosigmoid              Tubular adenoma                                                                    Low-grade       5 mm                          FF
  AD11            55        F            Asc colon                 Tubular adenoma                                                                    Low-grade       10 mm                         FF
  AD12            76        M            Cecum, sigmoid            Tubular adenoma                                                                    Low-grade       5 mm, 8-10 mm                 FF
  AD13            62        F            Sigmoid                   Tubular adenoma                                                                    High-grade      30 mm                         FF
  AD14            83        M            Asc colon                 Tubulovillous adenoma                                                              High-grade      50-60 mm                      FF
  AD15            73        M            Cecum, asc, desc          Tubular adenoma                                                                    Low-grade       12 mm, 10 mm, 6-8 mm          FF
  AD16            64        M            Transv, sigmoid, rectum   Tubular adenoma                                                                    Low-grade       5 mm, 25 mm, 15 mm            FF
  AD17            63        M            Asc, transv, rectum       Tubular adenoma                                                                    Low-grade       2-3 mm, 5 mm, 5-6 mm, 15 mm   FF
  AD18            63        F            Sigmoid                   Tubulovillous adenoma                                                              Low-grade       25 mm                         FF
  AD19            63        M            Rectum                    Tubulovillous and tubular adenoma                                                  Low-grade       25 mm, 30 mm                  FF
  AD20            87        M            Sigmoid, rectum           Tubulovillous adenoma                                                              Low-grade       20 mm, 15 mm                  FF
  AD21            63        F            Sigmoid                   Tubulovillous adenoma                                                              Low-grade       25 mm                         FF
  CRC1            67        F            Sigmoid                   Adenocarcinoma                      Unknown   Unknown     Unknown                                                                FF
  CRC2            76        F            Hepatic flexure           Adenocarcinoma                      T2N0M0    2           B1                                                                     FF
  CRC3            73        F            Sigmoid                   Adenocarcinoma                      T3N2M1    2           D                                                                      FF
  CRC4            65        M            Sigmoid                   Adenocarcinoma                      T2N0M0    1           B1                                                                     FF
  CRC5            85        F            Cecum                     Adenocarcinoma                      T2N0M0    2           B1                                                                     FF
  CRC6            60        M            Hepatic flexure           Adenocarcinoma                                unknown     D                                                                      FF
  CRC7            68        M            Sigmoid, rectum           Adenocarcinoma                      T3N0M0    1           B2                                                                     FF
  CRC8            87        F            Sigmoid                   Adenocarcinoma                      T3N0M0    2           B2                                                                     FF

Ch: Children; N: Normal; Ad: Adenoma; CRC: Colorectal cancer.

DNA isolation
-------------

Tissue samples were homogenized in 2% sodium dodecyl sulphate, and digested with 4 mg/mL proteinase K for 16 h at 56 °C. Genomic DNA was isolated using the High Pure PCR Template Preparation Kit (Roche Applied Science) according to the manufacturer's instructions\[[@B18]\]. DNA was eluted in 2 × 100 μL RNase- and DNase-free water and stored at -20 °C. The quantity of the isolated DNA samples was measured by Qubit fluorometer using the Qubit dsDNA HS Assay (Invitrogen, ThermoFisher Scientific).

Bisulfite-specific PCR and MS-HRM experiments for SFRP1 promoter methylation analysis
-------------------------------------------------------------------------------------

Bisulfite conversion was performed using the EZ DNA Methylation Direct™ Kit (Zymo Research, Irvine, CA, United States) according to the manufacturer's instructions. For fresh frozen samples, 500 ng isolated DNA was converted, while for FFPE samples the total recovered DNA after deparaffinization and digestion was bisulfite converted. Bisulfite-specific PCR (BS-PCR) reactions were performed in 15 μL volume using LightCycler 480 Probes Master (Roche Applied Science), LightCycler^®^ 480 ResoLight Dye (Roche), *SFRP1* primers at 0.2 μmol/L final concentrations and bisulfite converted DNA (bcDNA) samples (approx, 5 ng bcDNA/well). The sequences of the applied SFRP1 BS-PCR primers were previously described\[[@B19]\]. Real-time PCR amplification was carried out on LightCycler 480 System with the following thermocycling conditions: 95 °C for 10 min, then 95 °C for 30 s, 62 °C with 0.4 °C decreasement/cycle for 30 s, 72 °C for 30 s for 10 touchdown cycles, followed by the amplification at 95 °C for 30 s, 58 °C for 30 s, and 72 °C for 30 s in 50 cycles. For HRM calibration, unmethylated and methylated bisulfite converted control DNA (EpiTect PCR Control DNA Set, Qiagen) were used in different ratios (0%, 10%, 25%, 50%, 75% and 100% methylated controls). HRM analyis was performed according to the following thermal conditions: after denaturation at 95 °C for 1 min, and cooling at 40 °C for 1 min, the reactions were continuously warmed up to 95 °C with a 25 acquisition/°C rate. Raw HRM data were exported and the HRM peak heights of the negative derivative of fluorescence over temperature curves (-(d/dT) Fluorescence) of the biological samples were retrieved at the melting temperatures of the methylated and unmethylated standards. The methylation percent was calculated by the ratio of values at the methylated and unmethylated melting temperatures. For statistical evaluation normal distribution was determined and the applied tests were chosen according to the above-mentioned criteria.

SFRP1 immunohistochemistry
--------------------------

Parallel with our epigenetic examinations, 4 nm thick FFPE samples from healthy children (*n =* 6) and healthy adults (*n =* 7) were examined. SFRP1 immunohistochemistry was performed on colonic tissue samples of healthy adults (*n =* 7; mean age at histology examination: 48 ± 17 years; 5 f/2 m) and of children (mean age: 12 ± 6 years); 3 f/3 m). Histology was diagnosed by an expert pathologist on routinely stained HE sections. Following deparaffinization and rehydration, microwave based antigen retrieval was performed in TRIS EDTA buffer (pH 9.0) (900 W/10 min, then 340 W/40 min). Samples were immunostained with SFRP1 polyclonal antibody (ab4193, Abcam, Cambridge, United Kingdom, 1:80 dilution) with diaminobenzidine - hydrogen peroxidase - chromogen-substrate system (cat\#30014.K, HISTOLS-DAB, Histopathology Ltd., Hungary) and were digitalized by Pannoramic 250 Flash II scanner (with Zeiss Plan-Apochromat 20 × objective; 3DHISTECH Ltd, Hungary). Digital slides were semi-quantitatively analyzed with Pannoramic Viewer (ver.:1.15.3; 3DHISTECH) based on Q-score method (scored by multiplying the percentage of positive cells (P) by the intensity (I: +3, +2, +1, 0). Formula: Q = P × I; Maximum = 300). Epithelial and stromal compartments were examined separately, then these scores were summarized (Σ) (Σ Q-score maximum: 600) in order to have comparable results with our whole biopsy methylation analyses.

Statistical analysis
--------------------

The applied statistical methods are outlined above after the descriptions of molecular and *in silico* analyses. The statistical review of the study was performed by a biomedical statistician.

RESULTS
=======

Gene ontology of 353 CpG sites of the \"epigenetic clock\"
----------------------------------------------------------

The "epigenetic clock" signature includes 353 CpG sites\[[@B2]\] including different genes, gene promoters and other genomic regions such as enhancers, insulators, Polycomb-repressed regions. From the above 353 CpG sites, DNA methylation levels of 193 were positively and of 160 were negatively correlated with age\[[@B2]\]. First we updated the annotation of the CpG sites and assigned official gene symbols according to the newest version of NCBI Gene Database. Approximately 80% of the genes belonging to 353 CpG sites could be classified into functional groups including highly represented transcriptional regulation, translation (15.93%), metabolism (12.36%), development and ontogenesis (8.24%) and transport (8.24%). Approximately 20% of the genes had unknown function. According to the Encode ChromHMM results of nine human cell lines, the majority of the 353 CpG sites (76.2 %) were located in the promoter regions of genes. Also, 57.2% of them were categorized as active promoters (declared if it was found "active promoter" in at least one of the nine analyzed cell lines), while 19% were found to be "weak promoter" ("weak promoter" in at least one of the nine analyzed cell lines). One fourth (23.8%) of the CpG sites was located in non-promoter regions such as enhancers, insulators, transcribed and repressed regions (Supplementary Table [1](#T1){ref-type="table"}).

In silico DNA methylation analysis
----------------------------------

Analysis of the Illumnina Beadchip450K methylation array data set of Luo et al\[[@B24]\] showed 137 (38.8%) of the epigenetic clock CpG sites were found to be significantly differentially methylated between CRC and normal tissue samples (*P \<* 0.05). Approximately two third of these CpG sites had similar methylation changes in CRC samples as during aging, while one third of these CpG sites showed opposite alterations in CRC tissue as during aging (Supplementary Table [1](#T1){ref-type="table"}). Among these, 57 CpG sites showed at least a 10% methylation difference: from the 57 CpG sites 45 were hypermethylated (including *ADHFE1*/cg08090772, *MCAM*/cg21096399, *DKK3*/cg13216057, *SFRP1*/cg02388150, *SYNE1*/cg26620959), while 12 CpG sites showed hypomethylation (such as *MGP*/cg00431549, *PIPOX*/cg06144905, *STRA6*/cg00075967, *ERG*/cg17274064) in CRCs (*P \<* 0.05, Δβ ≥ 10%) (Table [2](#T2){ref-type="table"}, Supplementary Table [1](#T1){ref-type="table"}). In the adenoma *vs* normal comparison, DNA methylation of 165 CpG sites (46.7%) were significantly altered from which 70 CpG sites showed a ≥ 10% methylation difference: 36 CpG sites were hypermethylated (*e.g*., *SDC2*/cg25070637, *SFRP1*/cg02388150, *SYNE1*/cg26620959) and 34 showed decreased methylation levels (including *CEMIP*/cg20828084, *SPATA18*/cg03103192, *STRA6*/cg00075967) in adenoma samples (*P \<* 0.05, Δβ ≥ 10%) (Table [3](#T3){ref-type="table"}). In CRC samples 33 CpG sites were found to be hypermethylated (such as *KRT20*/cg00091693, *STRA6*/cg00075967, *UROS*/cg19346193) and only one (*LTBP3*/cg08965235) was hypomethylated compared to adenomas (*P \<* 0.05, Δβ ≥ 10%) (Table [4](#T4){ref-type="table"}). A heatmap for the differentially methylated epigenetic clock CpG sites (*P \<* 0.05, Δβ ≥ 10%), with hierarchical cluster analysis results of normal, adenoma and CRC samples is shown in Figure [1](#F1){ref-type="fig"}.

![DNA methylation heatmap of normal, adenoma and colorectal carcinoma samples according to the methylation status of age-related CpG sites. From the 353 epigenetic clock CpG sites (cg IDs)\[[@B2]\] significantly differentially methylated in CRC *vs* normal, adenoma *vs* normal and CRC *vs* adenoma comparisons were selected and colonic tissue samples (GSE48684\[[@B24]\]) were classified according to their methylation levels. The analyzed samples are illustrated on X axis, significantly altered CpG sites (cg IDs) are represented on Y axis. DNA methylation intensities (β values) are visualized, red shows hypermethylation, while hypomethylation was marked with green color. CRC: Colorectal carcinoma (light green); Ad: Adenoma (dark blue); N: Normal (light blue).](WJG-22-10325-g001){#F1}

###### 

Significant DNA methylation alterations of age-related CpG sites in CRC samples compared to normal tissue

  **cgID**     **Gene symbol**   ***P* value**    **Δβ (CRC - N)**
  ------------ ----------------- ---------------- ------------------
  cg06462291   NT5DC3            3.81 × 10^-6^    -0.27
  cg06144905   PIPOX             1.81 × 10^-7^    -0.22
  cg10345936   SLC36A2           2.49 × 10^-5^    -0.18
  cg13828047   MPI               1.78 × 10^-5^    -0.17
  cg11314684   AKT3              4.55 × 10^-5^    -0.16
  cg00431549   MGP               0.020            -0.12
  cg14409958   ENPP2             0.021            -0.11
  cg00091693   KRT20             0.010            -0.11
  cg17274064   ERG               1.48 × 10^-4^    -0.11
  cg22809047   RPL31             1.91 × 10^-3^    -0.10
  cg00075967   STRA6             0.010            -0.10
  cg06952310   NCAN              7.13 × 10^-3^    -0.10
  cg02388150   SFRP1             3.33 × 10^-3^    0.10
  cg03588357   GPR68             7.72 × 10^-3^    0.10
  cg26297688   TMEM263           6.21 × 10^-3^    0.10
  cg04528819   KLF14             0.036            0.10
  cg26372517   TFAP2E            9.23 × 10^-3^    0.11
  cg08030082   POMC              1.93 × 10^-3^    0.11
  cg05675373   KCNC4             7.80 × 10^-3^    0.11
  cg10281002   TBX5              0.012            0.11
  cg06117855   CLEC3B            1.87 × 10^-3^    0.11
  cg09509673   CCR10             1.91 × 10^-4^    0.11
  cg14597908   GNAS              1.48 × 10^-4^    0.11
  cg27494383   LTK               9.32 × 10^-3^    0.12
  cg21870884   GPR25             5.77 × 10^-3^    0.13
  cg25657834   NTSR2             4.43 × 10^-3^    0.13
  cg22449114   TCF15             3.48 × 10^-5^    0.13
  cg04126866   C10orf99          4.52 × 10^-4^    0.13
  cg25552492   LGI3              9.44 × 10^-3^    0.14
  cg08965235   LTBP3             3.12 × 10^-3^    0.14
  cg06836772   PRKAA2            0.013            0.14
  cg02364642   ARHGEF25          1.20 × 10^-3^    0.16
  cg18573383   KCNC2             1.38 × 10^-3^    0.16
  cg12616277   ESYT3             0.015            0.16
  cg17729667   NINL              3.46 × 10^-3^    0.16
  cg04999691   ZBED6CL           3.32 × 10^-11^   0.16
  cg12373771   CECR6             3.70 × 10^-3^    0.17
  cg02489552   CCDC105           8.91 × 10^-8^    0.17
  cg25148589   GRIA2             7.77 × 10^-6^    0.19
  cg21096399   MCAM              5.47 × 10^-6^    0.19
  cg20914508   GAP43             4.24 × 10^-4^    0.20
  cg12768605   LYPD5             1.85 × 10^-4^    0.21
  cg13216057   DKK3              2.10 × 10^-4^    0.21
  cg12351433   LHCGR             4.97 × 10^-7^    0.22
  cg08434234   DGKI              5.16 × 10^-5^    0.23
  cg10920957   JPH3              3.00 × 10^-4^    0.26
  cg27092035   ARL10             3.73 × 10^-5^    0.27
  cg06557358   TMEM132E          3.17 × 10^-6^    0.27
  cg26620959   SYNE1             1.32 × 10^-6^    0.30
  cg07663789   NPR3              8.73 × 10^-6^    0.31
  cg09191327   PRDM12            1.79 × 10^-6^    0.31
  cg25070637   SDC2              1.64 × 10^-6^    0.34
  cg10486998   GALR1             1.81 × 10^-8^    0.35
  cg24834740   PPP1R16B          3.56 × 10^-12^   0.37
  cg27319898   ZNF804B           5.41 × 10^-8^    0.38
  cg08090772   ADHFE1            7.18 × 10^-14^   0.39
  cg02217159   KHDRBS2           6.67 × 10^-13^   0.43

N: Normal; CRC: Colorectal cancer.

###### 

Significant DNA methylation changes of age-related CpG sites in adenoma samples compared to normal tissue

  **cgID**     **Gene symbol**   ***P* value**    **Δβ (AD - N)**
  ------------ ----------------- ---------------- -----------------
  cg10345936   SLC36A2           3.49 × 10^-10^   -0.34
  cg00091693   KRT20             2.49 × 10^-12^   -0.30
  cg00075967   STRA6             2.58 × 10^-9^    -0.26
  cg11314684   AKT3              1.03 × 10^-9^    -0.26
  cg06462291   NT5DC3            7.45 × 10^-5^    -0.25
  cg17099569   GLI2              1.25 × 10^-10^   -0.23
  cg00168942   GJD4              2.48 × 10^-7^    -0.20
  cg20828084   CEMIP             1.33 × 10^-9^    -0.19
  cg17274064   ERG               1.82 × 10^-10^   -0.19
  cg07408456   PGLYRP2           2.41 × 10^-12^   -0.19
  cg03019000   TEX264            2.25 × 10^-7^    -0.19
  cg17589341   SLC14A1           1.42 × 10^-9^    -0.19
  cg02580606   KRT33B            9.08 × 10^-5^    -0.17
  cg00436603   CYP2E1            1.37 × 10^-8^    -0.16
  cg19346193   UROS              6.59 × 10^-7^    -0.15
  cg03103192   SPATA18           1.39 × 10^-7^    -0.15
  cg25564800   KPNA1             2.18 × 10^-8^    -0.14
  cg06144905   PIPOX             3.63 × 10^-7^    -0.14
  cg06952310   NCAN              2.72 × 10^-4^    -0.14
  cg13038560   C2orf47           2.13 × 10^-5^    -0.13
  cg22190114   NLRP8             1.67 × 10^-4^    -0.13
  cg13302154   MGP               7.27 × 10^-6^    -0.13
  cg01262913   DSCR9             2.67 × 10^-6^    -0.13
  cg14258236   OR5V1             3.71 × 10^-4^    -0.12
  cg13828047   MPI               1.01 × 10^-3^    -0.12
  cg01459453   SELP              1.65 × 10^-4^    -0.12
  cg14894144   LAMA3             2.29 × 10^-4^    -0.12
  cg07337598   ANXA9             2.02 × 10^-5^    -0.12
  cg03270204   DDR1              7.47 × 10^-5^    -0.12
  cg12946225   HMG20B            1.37 × 10^-6^    -0.11
  cg09646392   TNFSF13B          2.66 × 10^-5^    -0.10
  cg19305227   SLC28A2           0.033            -0.10
  cg03578041   LARP6             2.22 × 10^-5^    -0.10
  cg07455279   NDUFA3            0.013            -0.10
  cg13899108   PDE4C             5.00 × 10^-6^    0.10
  cg04999691   ZBED6CL           4.92 × 10^-5^    0.10
  cg14597908   GNAS              9.38 × 10^-5^    0.10
  cg21870884   GPR25             9.49 × 10^-3^    0.11
  cg12616277   ESYT3             0.022            0.12
  cg12373771   CECR6             3.55 × 10^-3^    0.12
  cg17729667   NINL              4.43 × 10^-3^    0.13
  cg02364642   ARHGEF25          2.33 × 10^-3^    0.14
  cg22449114   TCF15             2.39 × 10^-5^    0.14
  cg03565323   ZNF287            4.52 × 10^-3^    0.14
  cg02388150   SFRP1             1.20 × 10^-7^    0.15
  cg12768605   LO×L2             8.01 × 10^-3^    0.15
  cg25657834   NTSR2             1.46 × 10^-4^    0.16
  cg20914508   GAP43             9.41 × 10^-4^    0.16
  cg10281002   TBX5              1.26 × 10^-5^    0.17
  cg02489552   CCDC105           7.16 × 10^-8^    0.18
  cg05675373   KCNC4             1.82 × 10^-6^    0.18
  cg25148589   GRIA2             6.11 × 10^-7^    0.18
  cg13216057   DKK3              9.64 × 10^-4^    0.18
  cg27092035   ARL10             8.81 × 10^-4^    0.19
  cg12351433   LHCGR             2.20 × 10^-6^    0.20
  cg18573383   KCNC2             5.43 × 10^-7^    0.21
  cg08434234   DGKI              6.60 × 10^-5^    0.22
  cg21096399   MCAM              5.20 × 10^-8^    0.22
  cg10920957   JPH3              1.03 × 10^-4^    0.25
  cg08965235   LTBP3             6.03 × 10^-10^   0.25
  cg27319898   ZNF804B           5.48 × 10^-5^    0.26
  cg26620959   SYNE1             3.89 × 10^-6^    0.29
  cg25070637   SDC2              1.82 × 10^-5^    0.30
  cg07663789   NPR3              6.41 × 10^-7^    0.31
  cg09191327   PRDM12            4.08 × 10^-7^    0.31
  cg06557358   TMEM132E          2.04 × 10^-8^    0.33
  cg10486998   GALR1             2.61 × 10^-9^    0.36
  cg24834740   PPP1R16B          2.23 × 10^-9^    0.36
  cg08090772   ADHFE1            5.19 × 10^-11^   0.39
  cg02217159   KHDRBS2           1.87 × 10^-11^   0.41

N: Normal; Ad: Adenoma.

###### 

Significant DNA methylation alterations of age-related CpG sites in colorectal cancer samples compared to adenoma tissue

  **cgID**     **Gene symbol**   ***P* value**    **Δβ (CRC - AD)**
  ------------ ----------------- ---------------- -------------------
  cg08965235   LTBP3             9.09 × 10^-4^    -0.11
  cg00945507   SEC61G            1.64 × 10^-5^    0.10
  cg15974053   HSD17B14          2.27 × 10^-3^    0.10
  cg24262469   TIPARP            5.33 × 10^-8^    0.10
  cg07158339   FXN               1.84 × 10^-7^    0.10
  cg11314684   AKT3              4.52 × 10^-4^    0.10
  cg03578041   LARP6             2.57 × 10^-9^    0.10
  cg17853587   NDST3             5.94 × 10^-4^    0.10
  cg07408456   PGLYRP2           1.51 × 10^-7^    0.11
  cg02580606   KRT33B            1.22 × 10^-4^    0.11
  cg03019000   TEX264            5.39 × 10^-5^    0.11
  cg27319898   ZNF804B           0.023            0.12
  cg00436603   CYP2E1            1.97 × 10^-6^    0.12
  cg15804973   MAP3K5            6.27 × 10^-12^   0.12
  cg06117855   CLEC3B            1.73 × 10^-7^    0.13
  cg24126851   DCHS1             3.58 × 10^-8^    0.13
  cg16034652   UNC79             4.23 × 10^-11^   0.13
  cg01262913   DSCR9             1.64 × 10^-8^    0.13
  cg26372517   TFAP2E            9.80 × 10^-6^    0.13
  cg03270204   DDR1              4.24 × 10^-7^    0.13
  cg17589341   SLC14A1           7.35 × 10^-10^   0.13
  cg22679120   SNX8              8.16 × 10^-9^    0.14
  cg20828084   CEMIP             2.00 × 10^-8^    0.14
  cg19305227   SLC28A2           1.11 × 10^-6^    0.14
  cg00168942   GJD4              1.18 × 10^-7^    0.14
  cg13038560   C2orf47           8.96 × 10^-8^    0.15
  cg26614073   SCAP              1.33 × 10^-9^    0.15
  cg19346193   UROS              2.09 × 10^-8^    0.16
  cg00075967   STRA6             4.87 × 10^-7^    0.16
  cg03103192   SPATA18           6.07 × 10^-12^   0.16
  cg10345936   SLC36A2           4.09 × 10^-6^    0.16
  cg17099569   GLI2              9.04 × 10^-7^    0.16
  cg04126866   C10orf99          4.23 × 10^-10^   0.18
  cg00091693   KRT20             1.17 × 10^-8^    0.19

N: Normal; Ad: Adenoma; CRC: Colorectal cancer.

In silico gene expression analysis
----------------------------------

Genes belonging to 353 age-related CpG sites were mapped to 768 Affymerix transcript IDs. In the CRC *vs* N comparison, 215 "epigenetic clock" genes were found to be significantly differentially expressed (*P \<* 0.05), of which 117 were altered with absolute logFC \> 0.5 (70 upregulated such as *ERG*, *MGP*, *MCAM*, *CEMIP* and 47 downregulated like *SFRP1*, *KRT20*, *CLEC3B*, *SYNE1*) (Supplementary Table 2A). Expression of 196 "epigenetic clock" genes changed significantly (*P \<* 0.05) in adenoma samples compared to healthy normal controls, 102 with absolute logFC higher than 0.5 (47 overexpressed such as *CEMIP*, *PLK1*, *CCNF* and 55 underexpressed like *SFRP1*, *SDC2*, *SYNE1*) (Supplementary Table 2B). Forty-three genes including *MCAM*, *MGP* and *AKT3* showed increased expression in CRC compared to adenoma samples, while 17 genes including *CEMIP*, *SPATA18* were downregulated (*P \<* 0.05, absolute logFC \> 0.5) (Supplementary Table 2C).

For genes with an inverse relation between gene expression and promoter methylation, the genes with both significant mRNA expression changes with absolute logFC \> 0.5 and significant DNA methylation alterations with at least 10% difference were taken into consideration. Based on these criteria, eleven genes, including *ERG*, *MGP*, *PIPOX*, *CLEC3B*, *LTK*, *SFRP1* and *SYNE1* were found to be inversely expressed with the promoter methylation status in CRC compared to normal tissue. Compared to the promoter methylation alterations, the expression of 8 genes, including *CEMIP*, *SPATA18*, *SDC2*, *SFRP1* and *SYNE1* changed oppositely in AD *vs* N comparison, while in CRC *vs* AD tissues 3 genes, namely *CEMIP*, *SPATA18* and *SLC28A2* showed this expression pattern. The genes showing an inverse relation between gene expression and DNA methylation in CRC *vs* normal, AD *vs* normal and CRC *vs* AD comparisons are represented in Table [5](#T5){ref-type="table"}.

###### 

Genes showing inverse DNA methylation and gene expression data

  **Gene symbol**   **Gene name**                                             **DNA methylation**   **Gene expression**                                            
  ----------------- --------------------------------------------------------- --------------------- --------------------- ------- --------------- ---------------- -------
  CRC *vs* N                                                                                                                                                       
  AKT3              AKT serine/threonine kinase 3                             cg11314684            4.55 × 10^-5^         -0.16   224229_s\_at    0.015            0.07
  222880_at         2.26 × 10^-3^                                             0.61                                                                                 
  212609_s\_at      4.72 × 10^-4^                                             0.62                                                                                 
  212607_at         9.76 × 10^-4^                                             0.64                                                                                 
  ERG               v-ets avian erythroblastosis virus E26 oncogene homolog   cg17274064            1.48 × 10^-4^         -0.11   211626_x\_at    5.84 × 10^-4^    0.20
  241926_s\_at      2.05 × 10^-5^                                             0.64                                                                                 
  213541_s\_at      4.69 × 10^-9^                                             1.08                                                                                 
  MGP               Matrix Gla protein                                        cg00431549            0.020                 -0.12   202291_s\_at    2.34 × 10^-11^   1.97
  PIPOX             Pipecolic acid and sarcosine oxidase                      cg06144905            1.81 × 10^-7^         -0.22   221605_s\_at    0.019            0.50
  CCR10             C-C motif chemokine receptor 10                           cg09509673            1.91 × 10^-4^         0.11    220565_at       0.010            -0.51
  CLEC3B            C-type lectin domain family 3 member B                    cg06117855            1.88 × 10^-3^         0.11    205200_at       1.45 × 10^-13^   -1.79
  LTK               Leukocyte receptor tyrosine kinase                        cg27494383            9.32 × 10^-3^         0.12    217184_s\_at    2.14 × 10^-11^   -1.32
  207106_s\_at      2.00 × 10^-5^                                             -0.75                                                                                
  PPP1R16B          Protein phosphatase 1 regulatory subunit 16B              cg24834740            3.56 × 10^-12^        0.37    41577_at        1.76 × 10^-4^    -0.79
  212750_at         7.68 × 10^-3^                                             -0.48                                                                                
  PRKAA2            Protein kinase AMP-activated catalytic subunit alpha 2    cg06836772            0.013                 0.14    227892_at       4.15 × 10^-3^    -0.87
  238489_at         4.67 × 10^-3^                                             -0.22                                                                                
  SFRP1             Secreted frizzled related protein 1                       cg02388150            3.33 × 10^-3^         0.10    202036_s\_at    8.66 × 10^-8^    -1.47
  202037_s\_at      3.98 × 10^-5^                                             -1.11                                                                                
  202035_s\_at      0.039                                                     -0.28                                                                                
  SYNE1             Spectrin repeat containing nuclear envelope protein 1     cg26620959            1.32 × 10^-6^         0.30    209447_at       4.27 × 10^-5^    -0.63
  AD *vs* N                                                                                                                                                        
  CEMIP             Cell migration inducing hyaluronan binding protein        cg20828084            1.33 × 10^-9^         -0.17   1554685_a\_at   1.71 × 10^-11^   1.12
  212942_s\_at      2.41 × 10^-43^                                            6.88                                                                                 
  NT5DC3            5\'-nucleotidase domain containing 3                      cg06462291            7.45 × 10^-5^         -0.25   218786_at       6.83 × 10^-9^    0.76
  SPATA18           Spermatogenesis associated 18                             cg03103192            1.39 × 10^-7^         -0.15   230723_at       4.41 × 10^-5^    0.45
  229331_at         1.20 × 10^-10^                                            1.50                                                                                 
  DKK3              Dickkopf WNT signaling pathway inhibitor 3                cg13216057            9.64 × 10^-4^         0.18    202196_s\_at    9.82 × 10^-5^    -0.65
  214247_s\_at      1.52 × 10^-4^                                             -0.50                                                                                
  PPP1R16B          Protein phosphatase 1 regulatory subunit 16B              cg24834740            2.23 × 10^-9^         0.36    41577_at        1.20 × 10^-10^   -1.44
  212750_at         3.28 × 10^-7^                                             -0.81                                                                                
  SDC2              Syndecan 2                                                cg25070637            1.82 × 10^-5^         0.30    212158_at       1.74 × 10^-10^   -1.17
  212157_at         2.14 × 10^-8^                                             -0.66                                                                                
  212154_at         9.19 × 10^-5^                                             -0.64                                                                                
  SFRP1             Secreted frizzled related protein 1                       cg02388150            1.20 × 10^-7^         0.15    202036_s\_at    3.62 × 10^-13^   -1.79
  202037_s\_at      4.43 × 10^-11^                                            -1.48                                                                                
  202035_s\_at      0.016                                                     -0.32                                                                                
  SYNE1             Spectrin repeat containing nuclear envelope protein 1     cg26620959            3.89 × 10^-6^         0.29    209447_at       5.76 × 10^-15^   -1.19
  CRC *vs* AD                                                                                                                                                      
  CEMIP             Cell migration inducing hyaluronan binding protein        cg20828084            2.00 × 10^-8^         0.14    212942_s\_at    9.88 × 10^-3^    -1.17
  SLC28A2           Solute carrier family 28 member 2                         cg19305227            1.11 × 10^-6^         0.14    207249_s\_at    0.027            -1.24
  SPATA18           Spermatogenesis associated 18                             cg03103192            6.07 × 10^-12^        0.16    229331_at       3.52 × 10^-9^    -1.73
  230723_at         7.35 × 10^-4^                                             -0.41                                                                                

N: Normal; Ad: Adenoma; CRC: Colorectal cancer.

In the comparison of healthy young colonic samples and normal adult tissues, 150 genes showed significantly altered expression from which 94 genes with absolute logFC \> 0.5 including overexpressed *LTBP3*, *REEP1*, *MGP*, *PLK1*, *SFRP1*, *SYNE1* and downregulated *PRKG2*, *PDCD6IP* and *TMEM56* (*P \<* 0.05) (Supplementary Table 2D). The pattern of expression of several genes including *SYNE1*, *CLEC3B*, *LTBP3* (Figure [2](#F2){ref-type="fig"}) and *SFRP1* (Figure [3A](#F3){ref-type="fig"}-C) was similar for increased age as that observed for cancer progression. However, there were some genes such as *MGP* (Figure [2](#F2){ref-type="fig"}) which showed similar expression pattern in young people and in cancer patients compared to healthy adult tissue.

![Genes showing both age- and carcinogenesis-related expression alterations. *SYNE1* (spectrin repeat containing nuclear envelope protein 1), *LTBP3* (latent transforming growth factor beta binding protein 3) and *CLEC3B* (C-type lectin domain family 3 member B) genes were downregulated during the colorectal carcinogenesis, similar decreasing expression was found during aging (significantly higher mRNA levels were detected in young colonic samples than in healthy adult biopsy specimens). MGP (matrix Gla protein) was overexpressed in children and in CRC samples compared to adenoma and healthy adults (*P* \< 0.035), hence its opposite expression was found during aging and colorectal carcinogenesis. X axis shows the analyzed sample groups, the normalized mRNA expression can be seen on Y axis. Red dots indicate the normalized mRNA expression values, boxplots represent the medians and standard deviations. Ch: Children; N: Normal; Ad: Adenoma; CRC: Colorectal cancer.](WJG-22-10325-g002){#F2}

![*SFRP1* mRNA expression and promoter DNA methylation alterations during aging and in different stages of colorectal carcinogenesis. *SFRP1* mRNA expression was significantly downregulated in adenoma and CRC samples compared to normal controls in case of all three Affymetrix probeset IDs representing *SFRP1* \[202035_s\_at: *P* \< 0.05 (A); 202036_s\_at: *P* \< 0.0003 (B); 202037_s\_at: *P* \< 0.005 (C)\]. In colonic biopsy samples of healthy young patients, higher *SFRP1* mRNA levels could be measured than in normal adults samples, this overexpression was proven to be significant in two of three transcript IDs \[202035_s\_at: *P* \< 0.05 (A); 202037_s\_at: *P* \< 0.005 (C)\]. *SFRP1* promoter region was significantly hypermethylated in CRC and adenoma tissue samples compared to normal adult and young colonic tissue (*P* \< 0.0001) (D). In pairwise comparison, DNA methylation of *SFRP1* promoter was slightly, but significantly increased in healthy adults compared to normal young samples (*P* \< 0.02) (E). The analyzed sample groups are illustrated on X axis, the normalized mRNA expression (A, B, C) and percentage of *SFRP1* promoter methylation (D, E) are represented on Y axis. Red dots indicate the normalized mRNA expression values (A, B, C) and the normalized DNA methylation percentage values (D, E), respectively. Boxplots represent the medians and standard deviations. Ch: Children; N: Normal; Ad: Adenoma; CRC: Colorectal cancer.](WJG-22-10325-g003){#F3}

Whole promoter methylation status of genes showing inverse relationship between gene expression and DNA methylation
-------------------------------------------------------------------------------------------------------------------

The DNA methylation status of whole promoter regions of genes showing an inverse relation between gene expression and DNA methylation (Table [5](#T5){ref-type="table"}) was determined using methyl capture sequencing data of 6 NAT, 15 adenoma and 9 CRC tissue samples\[[@B12]\]. In the CRC *vs* N/NAT comparison, similar DNA methylation alterations (such as hypomethylated *AKT3*, *MGP* promoters and hypermethylated *PPP1R16B*, *SFRP1*, *SYNE1* promoters) were observed in the promoter regions of 7 of the 11 inversely expressed genes (Table [6](#T6){ref-type="table"}). Between adenoma and normal samples, promoter regions of 7 of the 8 inversely expressed genes showed DNA methylation differences (*e.g*., hypomethylated *CEMIP/KIAA1199*, *SPATA18* promoters and hypermethylated *DKK3*, *SDC2*, *SFRP1*, *SYNE1* promoters) (Table [6](#T6){ref-type="table"}) as detected in case of age-related CpG sites. In CRC samples compared to adenoma tissue, significant hypermethylation of *CEMIP/KIAA199* promoter could be demonstrated in "epigenetic clock" CpG sites and whole promoter methylation analyses (Table [6](#T6){ref-type="table"}).

###### 

Whole promoter methylation status of genes with inverse age-related CpG site DNA methylation and gene expression data

  **Gene symbol**            **DNA methylation on age-related CpG site**   **Whole promoter DNA methylation status**                                                      
  -------------------------- --------------------------------------------- ------------------------------------------- ------- -------------------------- --------------- -------
  CRC *vs* N                                                                                                                                                              
  AKT3                       cg11314684                                    4.55 × 10^-5^                               -0.16   chr1:244005801-244005900   6.56 × 10^-3^   -0.33
  ERG                        cg17274064                                    1.48 × 10^-4^                               -0.11   chr21:39871501-39871600    0.044           -0.21
  MGP                        cg00431549                                    0.020                                       -0.12   chr12:15038501-15038600    0.030           -0.27
  CCR10                      cg09509673                                    1.91 × 10^-4^                               0.11    chr17:40835101-40835200    0.045           0.18
  chr17:40835201-40835300    0.022                                         0.26                                                                                           
  PPP1R16B                   cg24834740                                    3.56 × 10^-12^                              0.37    chr20:37433201-37433300    3.76 × 10^-3^   0.35
  chr20:37434701-37434800    0.048                                         0.40                                                                                           
  chr20:37435301-37435400    0.042                                         0.37                                                                                           
  SFRP1                      cg02388150                                    3.33 × 10^-3^                               0.10    chr8:41166001-41166100     0.017           0.44
  chr8:41166101-41166200     1.31 × 10^-4^                                 0.56                                                                                           
  chr8:41166201-41166300     3.40 × 10^-3^                                 0.49                                                                                           
  chr8:41166301-41166400     0.014                                         0.27                                                                                           
  chr8:41166401-41166500     1.28 × 10^-3^                                 0.53                                                                                           
  chr8:41166501-41166600     0.027                                         0.44                                                                                           
  chr8:41166601-41166700     0.034                                         0.39                                                                                           
  chr8:41166901-41167000     0.042                                         0.41                                                                                           
  SYNE1                      cg26620959                                    1.32 × 10^-6^                               0.30    chr6:152622201-152622300   0.027           0.35
  chr6:152957601-152957700   0.032                                         0.39                                                                                           
  chr6:152957701-152957800   0.043                                         0.40                                                                                           
  chr6:152958101-152958200   2.86 × 10^-4^                                 0.65                                                                                           
  AD *vs* N                                                                                                                                                               
  CEMIP                      cg20828084                                    1.33 × 10^-9^                               -0.17   chr15: 81070701-81070800   0.028           -0.25
  SPATA18                    cg03103192                                    1.39 × 10^-7^                               -0.15   chr4:52915901-52916000     0.042           -0.23
  DKK3                       cg13216057                                    9.64 × 10^-4^                               0.18    chr11:12029701-12029800    3.11 × 10^-3^   0.26
  chr11:12029801-12029900    1.67 × 10^-3^                                 0.33                                                                                           
  chr11:12029901-12030000    8.08 × 10^-5^                                 0.56                                                                                           
  chr11:12030001-12030100    0.047                                         0.15                                                                                           
  chr11:12030401-12030500    7.38 × 10^-3^                                 0.28                                                                                           
  chr11: 12030501-12030600   0.012                                         0.28                                                                                           
  PPP1R16B                   cg24834740                                    2.23 × 10^-9^                               0.36    chr20:37434201-37434300    0.045           0.26
  chr20:37434601-37434700    0.022                                         0.39                                                                                           
  chr20:37434701-37434800    0.013                                         0.39                                                                                           
  chr20:37434801-37434900    6.87 × 10^-3^                                 0.30                                                                                           
  chr20:37434901-37435000    1.70 × 10^-3^                                 0.44                                                                                           
  chr20:37435001-37435100    1.93 × 10^-3^                                 0.45                                                                                           
  chr20:37435101-37435200    6.49 × 10^-3^                                 0.35                                                                                           
  chr20:37435201-37435300    8.93 × 10^-4^                                 0.51                                                                                           
  chr20:37435301-37435400    0.014                                         0.42                                                                                           
  SDC2                       cg25070637                                    1.82 × 10^-5^                               0.30    chr8:97505901-97506000     2.30 × 10^-3^   0.59
  chr8:97506101-97506200     1.96 × 10^-4^                                 0.65                                                                                           
  chr8:97506201-97506300     8.43 × 10^-4^                                 0.63                                                                                           
  chr8:97506301-97506400     0.012                                         0.49                                                                                           
  chr8:97506401-97506500     0.019                                         0.47                                                                                           
  chr8:97506601-97506700     3.99 × 10^-3^                                 0.51                                                                                           
  chr8:97506701-97506800     0.021                                         0.45                                                                                           
  chr8:97506801-97506900     0.014                                         0.52                                                                                           
  chr8:97507101-97507200     0.015                                         0.44                                                                                           
  chr8:97507201-97507300     0.010                                         0.52                                                                                           
  chr8:97507301-97507400     3.47 × 10^-3^                                 0.59                                                                                           
  SFRP1                      cg02388150                                    1.20 × 10^-7^                               0.15    chr8:41165901-41166000     2.30 × 10^-3^   0.59
  chr8:41166001-41166100     1.57 × 10^-3^                                 0.59                                                                                           
  chr8:41166101-41166200     3.54 × 10^-4^                                 0.56                                                                                           
  chr8:41166201-41166300     1.49 × 10^-4^                                 0.60                                                                                           
  chr8:41166301-41166400     6.54 × 10^-3^                                 0.27                                                                                           
  chr8:41166401-41166500     1.32 × 10^-5^                                 0.55                                                                                           
  chr8: 41166501-41166600    2.30 × 10^-3^                                 0.60                                                                                           
  chr8:41166601-41166700     5.45 × 10^-3^                                 0.57                                                                                           
  chr8:41166701-41166800     8.15 × 10^-3^                                 0.51                                                                                           
  chr8:41166801-41166900     0.032                                         0.39                                                                                           
  chr8:41166901-41167000     0.019                                         0.45                                                                                           
  chr8:41167001-41167100     0.046                                         0.34                                                                                           
  chr8:41167101-41167200     0.025                                         0.41                                                                                           
  chr8:41167201-41167300     0.024                                         0.40                                                                                           
  SYNE1                      cg26620959                                    3.89 × 10^-6^                               0.29    chr6:152702701-152702800   0.012           0.20
  chr6:152702801-152702900   0.035                                         0.21                                                                                           
  chr6:152957501-152957600   6.05 × 10^-4^                                 0.37                                                                                           
  chr6:152957601-152957700   2.34 × 10^-4^                                 0.60                                                                                           
  chr6:152957701-152957800   0.017                                         0.51                                                                                           
  chr6:152957801-152957900   1.09 × 10^-3^                                 0.42                                                                                           
  chr6:152957901-152958000   1.03 × 10^-4^                                 0.57                                                                                           
  chr6:152958001-152958100   7.13 × 10^-4^                                 0.43                                                                                           
  chr6:152958101-152958200   1.72 × 10^-5^                                 0.72                                                                                           
  CRC *vs* AD                                                                                                                                                             
  CEMIP                      cg20828084                                    2.00 × 10^-8^                               0.14    chr15:81070701-81070800    7.59 × 10^-4^   0.31
  chr15:81070801-81070900    0.011                                         0.36                                                                                           

Only significant promoter DNA methylation alterations are represented in the Table. *P* \< 0.05.

SFRP1 promoter methylation analysis in healthy children, healthy adult, adenoma and CRC tissues
-----------------------------------------------------------------------------------------------

Based on the gene expression analysis results, *SFRP1* was found to be overexpressed in normal adult samples compared to adenoma and CRC biopsy specimens, and in healthy young patients even higher *SFRP1* mRNA levels could be detected than in normal adult samples (Figure [3A](#F3){ref-type="fig"}-C). As *SFRP1* is proven to be a methylation-regulated gene with literature data regarding its age-related DNA methylation alterations, hence it was chosen for detailed methylation analysis of normal, premalignant and cancerous colonic specimens including tissue samples from healthy children.

*SFRP1* promoter sequences were highly methylated in CRC samples (average methylation% = 55.0% ± 8.4%) and in adenoma tissue (49.9% ± 18.1 %), while low methylation levels could be measured in colonic tissues of both healthy adults (5.2% ± 2.7%) and children (2.2% ± 0.7%). Significant considerable hypermethylation was found in *SFRP1* promoter both between CRC and adult normal and between CRC and healthy children colonic tissue samples (*P \<* 0.0001) (Figure [3D](#F3){ref-type="fig"}). In the healthy adult *vs* healthy children comparison, significant, but moderate DNA methylation alterations were detected: in adults higher DNA methylation levels were found in the analyzed region of *SFRP1* promoter (*P* = 0.017) (Figure [3E](#F3){ref-type="fig"}).

SFRP1 protein expression in colonic tissue samples of healthy normal children and adults
----------------------------------------------------------------------------------------

In healthy children samples the epithelial layer showed strong (representative scoring values: +3 and +2), diffuse SFRP1 expression both in cytoplasmic and nuclear region (Q-score: 226.67 ± 17.51), whereas the stromal cells showed heterogeneous protein expression (scoring values: form +3 to 0; Q-score: 176.66 ± 18.61; ΣQ-score: 403.33 ± 22.51; Figure [4A](#F4){ref-type="fig"}). Among stromal cells subepithelial fibroblast and several immune cells showed strong cytoplasmic and/or nuclear SFRP1 expression. Not significantly, but remarkably lower (representative scoring value: +2) SFRP1 protein expression was detectable both in epithelial (Q-score: 202.14 ± 24.12) and stromal component (140.71 ± 41.47; Σ Q-score: 351.42 ± 68.66; Figure [4B](#F4){ref-type="fig"}) of adult persons (*P* values: 0.063, 0.073 and 0.105 respectively).

![SFRP1 protein expression in colonic tissue samples of healthy normal children and adults. Strong/moderate cytoplasmic and nuclear *SFRP1* expression both in epithelial and stromal compartments of healthy children (A) and healthy adult (B) samples. Digital microscopic images; magnification × 40; scale: 50 μm.](WJG-22-10325-g004){#F4}

DISCUSSION
==========

Cancer is considered a primary age-related disease\[[@B3]\], and therefore age-related molecular changes including epigenetic alterations such as epigenetic drift and epigenetic clock\[[@B1],[@B2]\] necessarily show relationship with carcinogenesis-associated differences. Besides global hypomethylation, local, genomic site specific hypermethylation principally in the promoter regions of tumor suppressor genes can occur during both processes\[[@B6]-[@B8]\].

In this study, the potential correspondence between age-related and CRC-associated DNA methylation changes was studied using the 353 epigenetic clock CpG sites published by Horvath\[[@B2]\] as a model for age-related DNA methylation changes. With the analysis of methyl capture sequencing and Illumina BeadChip450K methylation array data, the methylation status of age-related CpG sites and genes was determined during CRC development and progression, and the relevant mRNA expression changes were also evaluated. Among the differentially methylated/expressed age-related genes, *SFRP1* promoter methylation was further analyzed in healthy, premalignant and cancerous colonic tissue samples, including biopsy specimens from young children.

Similarly to previous findings\[[@B29]\], DNA methylation alterations in a considerable proportion of age-related CpG sites/gene promoters (approximately 40%) were observed in samples representing different stages of CRC formation and progression. Approximately two third of these CpG sites had similar DNA methylation alterations in CRC compared to normal tissue samples as during aging. When the effect of DNA methylation of epigenetic clock genes was studied, whole promoter methylation was also observed in addition to the analysis of DNA methylation status of representing age-related CpG sites.

In accordance with our results, hypermethylation of several genes belonging to aging-associated CpG sites such as *SFRP1*\[[@B7],[@B12],[@B15],[@B18]-[@B23]\], *TFAP2E*\[[@B30]\], *TBX5*\[[@B31]\], *GNAS*\[[@B32]\], *DKK3*\[[@B18],[@B33]\], *DGKI*\[[@B34]\], *SYNE1*\[[@B35]-[@B37]\], *SDC2*\[[@B38],[@B39]\], *ADHFE1*\[[@B40]-[@B42]\] was observed in tissue and/or blood samples of CRC patients. *SFRP1* tumor suppressor protein with a putative Wnt-binding site impedes the frizzled ligand - Wnt receptor interaction. Its reduced expression caused by promoter hypermethylation can lead to constitutive activation of Wnt pathway which is best characterized signaling pathway in CRC pathogenesis\[[@B7],[@B12],[@B15],[@B18]-[@B23],[@B43]\]. Worthley et al\[[@B15]\] showed strong positive correlation between *SFRP1* methylation and age (Spearmen's rank *P* = 0.72, *P \<* 0.0001) on a set of 166 CRC tissue samples from adults \[median age: 61.2 years (22.8-89.2 years)\]. In this study, the increase of *SFRP1* methylation during the aging was also observed, moreover to our best knowledge, we provide the first evidence of significantly lower *SFRP1* methylation levels in children (under 18 years) compared to healthy adult colonic tissues. Preliminary results of methylation-sensitive restriction enzyme methylation array analysis of our reseach groups suggested *SFRP1* hypomethylation in young colonic tissue samples, though the high standard deviations of methylation percentages and the low samples size limited our conclusions\[[@B18]\]. In accordance with the DNA methylation data, elevated mRNA and protein levels could be detected in colonic tissues of normal children compared to adults.

Dickkopf Wnt signaling pathway inhibitors including *DKK3* are also frequent targets of epigenetic silencing in gastrointestinal tumors promoting carcinogenesis by loss of/reduction their expression\[[@B33]\]. Hypermethylated syndecan 2 (*SDC2*) is a potential biomarker for early CRC detection both in serum and tissue, although the gene silencing effect of elevated promoter methylation is not unambiguous according to the literature data\[[@B44]\], moreover some observations support its tumorigenic activity in CRC\[[@B45]\]. Hypermethylation of spectrin repeat containing nuclear envelope protein 1 (*SYNE1*) suggests its tumor suppressor function in CRC\[[@B37]\], which was detected not only in CRC tissue samples\[[@B35],[@B36]\], but it appears to be a promising marker for blood-based CRC detection\[[@B37]\]. Alcohol dehydrogenase, iron containing 1 (*ADHFE1*) promoter hypermethylation was found to be associated with CRC differentiation\[[@B41]\], furthermore it is involved in cell proliferation induction by alcohol in colon carcinoma cells\[[@B46]\].

In the case of some genes like *AKT3*, *CEMIP* and *DDR1*, promoter hypomethylation was observed in different types of cancers such as breast cancer, lung cancer and CRC\[[@B47]-[@B49]\]. PI3K/Akt pathway is thought to be the most commonly activated intracellular signaling pathway in human malignancies\[[@B50]\]. AKT kinases including *AKT3* are remarkable contributors to malignant diseases as they are involved in the regulation of cell proliferation, growth and survival\[[@B50],[@B51]\]. Hypomethylation and overexpression of the cell migration-inducing protein (*CEMIP/KIAA1199*) was previously described in CRC\[[@B49],[@B52]\]. In our study, hypomethylation of this gene could be detected mainly in adenoma samples, however a slight but significant decrease in methylation level was observed in CRC samples compared to normal controls. In accordance with the methylation data, strong upregulation of *CEMIP* mRNAs was shown both in adenoma and CRC samples with higher expression values in adenoma tissue\[[@B53],[@B54]\]. Due to its robust overexpression at mRNA and also at protein levels, *CEMIP* is considered as a candidate prognostic marker for CRC and a potential therapeutic target\[[@B55]\]. *CEMIP* facilitates colon cancer cell proliferation *via* enhancing Wnt signaling\[[@B49]\] and promotes tumor growth\[[@B55]\] and cancer dissemination under hypoxic conditions\[[@B56]\].

In conclusion, our results regarding DNA methylation alterations of age-related, epigenetic clock genes during colorectal carcinogenesis supports the concept that aging is one of the main factors predisposing cancer including CRC. Several age-related DNA methylation alterations could be observed during development and progression of CRC affecting the mRNA expression of certain CRC- and adenoma-related key control genes. The main CRC-associated signal transduction pathways, such as WNT signaling and PI3K/Akt pathways are also influenced during aging.
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Background
----------

Cancer is considered a primary age-related disease, and therefore age-related molecular changes including epigenetic alterations such as epigenetic drift and epigenetic clock necessarily show relationship with carcinogenesis-associated differences. Besides global hypomethylation, local, genomic site specific hypermethylation principally in the promoter regions of tumor suppressor genes can occur during both processes.

Research frontiers
------------------

Several age-related DNA methylation alterations could be observed during colorectal cancer (CRC) formation and progression affecting the mRNA expression of certain CRC- and adenoma-related key control genes such as hypermethylated secreted frizzled related protein 1 (*SFRP1*), spectrin repeat containing nuclear envelope protein 1 and hypomethylated cell migration-inducing protein.
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For the first time significantly lower *SFRP1* methylation levels were demonstrated in colonic tissue from children (under 18 years) compared to healthy adults. The main CRC-associated signal transduction pathways, such as WNT signaling and PI3K/Akt pathways are also influenced during aging.
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In this paper, the authors analyzed the methylation and expression levels of 353 age-related "epigenetic clock" genes in colonic tissue samples. They identified many differentially methylated and/or differentially expressed genes. Among these genes, the DNA methylation and mRNA levels of *SFRP1* was further analyzed. This is an interesting work using a large number of data and the results may be useful in related field.
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